India is all set to launch on Thursday its first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for prevention of cervical cancer. It has been developed by the Serum Institute of India in partnership with the Department of Biotechnology. Till now, HPV vaccines needed to prevent cervical cancer have been sourced from foreign manufacturers at a cost of Rs 2,000 to Rs 3,500 per dose.
from Times of India https://ift.tt/EOZJNKo
via IFTTT
Wednesday, August 31, 2022
Free Press Journal | World News
The Indian Express | World News
The Indian Express | Sports
Times of India | World News Headlines, Latest International News, World Breaking News
The Guardian | World News
Dash & Outdoor Cameras from Rexing
Search cheapest worldwide Flight/Hotel/Cruise/Car/Activities
Travel Insurance
0 comments:
Post a Comment